Active, Not Recruiting
Study of AZD5305 as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Malignancies
NCT04644068
- Conditions
- Additional Indications Below for Module 4 and 5, Adnexal Diseases, Biliary Cancer, +66 more
- Locations
-
- Research Site Boston, Massachusetts, United States
- Research Site Boston, Massachusetts, United States
- Research Site New York, United States
- Research Site Oklahoma City, Oklahoma, United States